In summary, females with CIS or MS had decreased CD32b expression on naive and IgMhi MZ-like B cells compared with female controls, which was associated with increased serum BAFF and IgM, and seropositivity for EBV VCA IgM antibodies. Here, FCGR2B is linked to in situ carcinoma.